Previous studies have shown that low levels of YAP1 can block ABL1-induced apoptosis in hematological malignancies, while the genetic inactivation of MST1 restores YAP1 levels and causes cell death, both in vitro and in vivo. Here, ABL1 is linked to hematologic disorder.